CBPL.BO

Healthcare Medical Distribution

Chandra Bhagat Pharma Limited

₹49.40
+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap
372.73M
Avg Volume
2,287
P/E (TTM)
12.23
EPS
₹4.04
52W High
₹52.99
52W Low
₹29.70
Div. Yield
0.0%

Valuation

P/B Ratio
1.13
P/S Ratio
0.32
EV/EBITDA
10.34
EV/Revenue
0.42

Margins

Gross Margin 19.8%
Operating Margin 2.5%
Net Margin 2.6%
EBITDA Margin 4.1%

Growth & Returns

Revenue Growth (YoY)
251.7%
Earnings Growth (YoY)
1393.9%
Earnings Growth (QoQ)
1402.0%
Return on Equity
9.7%
Return on Assets
2.4%

Liquidity & Leverage

Current Ratio
1.50
Quick Ratio
1.02
Debt / Equity
0.50
Total Cash
47.79M
Total Debt
165.07M

About

Chandra Bhagat Pharma Limited, a pharmaceutical company, markets pharmaceutical critical care and health care products in India and internationally. The company offers pharmaceutical formulations, including intravenous and intramuscular injections, oral solids, tablets, capsules, liquid orals, syrup suspensions, injectable liquids, powders, lyophilized ampoules, vials, prefilled syringes, and small and large volume parenteral for various therapeutic categories, such as anti-cancer, anti-infective, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to hospitals and health care centers through its own distribution networks and sales force under its own brand. It also promotes and markets specialty chemicals, intermediates, and active pharmaceuticals ingredients. In addition, the company manufactures pharmaceuticals. It exports its products. Chandra Bhagat Pharma Limited was founded in 1944 and is based in Mumbai, India.

cbcpharma.com